HB 2557
AN ACT relating to prior authorization for prescription drug benefits
89th Regular Session
Jan 14, 2025 - Jun 2, 2025 • Session ended
Awaiting Committee Assignment
Bill filed, pending referral to House committee
Committee
Not yet assigned
Fiscal Note
Not available
What This Bill Does
Limits health insurance companies from requiring more than one prior authorization per year for prescription drugs used to treat chronic health conditions, such as autoimmune diseases, hemophilia, neurodegenerative diseases, and Von Willebrand disease. The law aims to reduce administrative burden for patients managing long-term health conditions by streamlining the prescription drug approval process. The changes will apply to health benefit plans delivered, issued, or renewed on or after January 1, 2026.
Subject Areas
Bill Text
relating to prior authorization for prescription drug benefits related to the treatment of chronic health conditions. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. The heading to Subchapter N, Chapter 1369, Insurance Code, is amended to read as follows: SUBCHAPTER N. COVERAGE OF PRESCRIPTION DRUGS FOR CHRONIC HEALTH CONDITIONS [AUTOIMMUNE DISEASES AND CERTAIN BLOOD DISORDERS] SECTION 2. Section 1369.651, Insurance Code, is amended to Sec. 1369.651. DEFINITIONS [DEFINITION]. In this (1) "Chronic health condition" means an illness, injury, impairment, or physical or mental condition that is expected to last at least one year and either: (A) requires ongoing medical attention to effectively manage or to prevent an adverse health event; or (B) limits one or more of the following (2) "Prescription [, "prescription] drug" has the meaning assigned by Section 551.003, Occupations Code. SECTION 3. Section 1369.654(a), Insurance Code, is amended (a) A health benefit plan issuer that provides prescription drug benefits may not require an enrollee to receive more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat a chronic health condition, including an autoimmune disease, hemophilia, neurodegenerative disease, or Von Willebrand disease. SECTION 4. The change in law made by this Act applies only to a health benefit plan that is delivered, issued for delivery, or renewed on or after January 1, 2026. A health benefit plan delivered, issued for delivery, or renewed before January 1, 2026, is governed by the law as it existed immediately before the effective date of this Act, and that law is continued in effect for SECTION 5. This Act takes effect September 1, 2025.
Bill History
Bill filed: AN ACT relating to prior authorization for prescription drug benefits
Related Guides
Learn more about tracking Texas legislation and working with lobbyists.
How to Read & Track Texas Bills
Master bill numbering, understand legislative language, and learn effective tracking strategies.
Understanding Texas Legislative Deadlines
Navigate the 140-day session with critical calendar dates and filing deadlines.
How Laws Get Made in Texas
Follow a bill's journey from filing to the governor's desk through committees and floor votes.
When Should Your Business Hire a Lobbyist?
Discover the signs that your business needs professional advocacy at the Texas Capitol.